Key Insights

Highlights

Success Rate

98% trial completion (above average)

Research Maturity

54 completed trials (89% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.6%

1 terminated out of 61 trials

Success Rate

98.2%

+11.7% vs benchmark

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

17%

9 of 54 completed with results

Key Signals

9 with results98% success

Data Visualizations

Phase Distribution

61Total
Not Applicable (4)
P 1 (56)
P 4 (1)

Trial Status

Completed54
Unknown3
Recruiting2
Not Yet Recruiting1
Terminated1

Trial Success Rate

98.2%

Benchmark: 86.5%

Based on 54 completed trials

Clinical Trials (61)

Showing 20 of 20 trials
NCT06107205Phase 1CompletedPrimary

Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects

NCT04029090Phase 1CompletedPrimary

A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects

NCT06929052Phase 1CompletedPrimary

A Comparative Pharmacokinetic Study of ADL-018 Autoinjector Compared to A Pre-filled Syringe in Healthy Subjects.

NCT04493281Phase 1CompletedPrimary

Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects

NCT04481750Phase 1CompletedPrimary

Study of Oral Edaravone in Healthy Adult Males

NCT05342597Phase 1CompletedPrimary

Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)

NCT04481789Phase 1CompletedPrimary

Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)

NCT04776135Phase 1CompletedPrimary

Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube

NCT07025434Not ApplicableRecruiting

Effects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults

NCT05909644Phase 1CompletedPrimary

An Open-label DDI Study of Omaveloxolone in Healthy Subjects

NCT04008186Phase 1CompletedPrimary

A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone

NCT05632211Phase 1CompletedPrimary

A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants

NCT04433208Not ApplicableCompletedPrimary

Dietary Supplement With and Without a Probiotic

NCT06857799Phase 1CompletedPrimary

A Study on the Safety, Tolerability and Pharmacokinetics of WS-0101 Tablets in Chinese Healthy Subjects

NCT04979572Phase 1CompletedPrimary

A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)

NCT04783766Phase 1Completed

Safety, Tolerability and Pharmacokinetics Study of CK-3773274

NCT04370431Phase 1CompletedPrimary

A Study of TTYP01 in Healthy Adult Subjects

NCT06635226Phase 1RecruitingPrimary

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects

NCT06701149Phase 1Not Yet RecruitingPrimary

A Comparative Study of the Pharmacokinetics of SIM0718 Injection in Healthy Adult Subjects in China

NCT06063291Phase 1CompletedPrimary

Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects

Scroll to load more

Research Network

Activity Timeline